Riskpilot← Back to searchSign inGet full accessCRYOOCYTE AS
ASActiveOrg 917808368Kanalsletta 2, 4033 StavangerSupport activities for fishing and aquaculture · NACE 0330Est. 20163 employees
Revenue 2024
NOK 2,2M
-44% vs 2023
EBITDA margin
-65.6%
+71% vs 2023
Equity ratio
58.3%
Financial strength
Net profit 2024
NOK -1,4M
+71% vs 2023
| Revenue | NOK 2,2M | -44% |
| EBITDA | NOK -1,4M | +71% |
| Net profit | NOK -1,4M | +71% |
| Total assets | NOK 4,9M | +66% |
| Equity | NOK 2,9M | -5% |
| Employees | 3 | — |
Legal name
CRYOOCYTE AS
Org number
917808368
Legal form
Aksjeselskap
NACE code
0330 · Support activities for fishing and aquaculture
Founded
24. oktober 2016
Share capital
NOK 8 530 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Tjenester tilknyttet hav- og kystbastert akvakultur, annen forskning og utviklingsarbeid innen naturvitenskap og teknikk samt annet som naturlig faller sammen med dette.
Address
Kanalsletta 2, 4033 Stavanger
Phone
+4751217110
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 806 | 3 396 | 1 305 | 0 | 997 | 3 846 | 2 154 |
| Staff expenses | −106 | −473 | −1 542 | −1 520 | −1 288 | −1 185 | −622 | −1 886 | −1 267 |
| EBITDA | −106 | −1 153 | −2 083 | −4 812 | −1 831 | −1 547 | −378 | −4 928 | −1 414 |
| Depreciation & amort. | −0 | −14 | −25 | −45 | −61 | −9 | −8 | −7 | −6 |
| EBIT | −106 | −1 167 | −2 108 | −4 857 | −1 892 | −1 556 | −386 | −4 936 | −1 420 |
| Net financials | 0 | −4 | −31 | −46 | −12 | −1 | 0 | 1 | −25 |
| Profit before tax | −106 | −1 171 | −2 139 | −4 903 | −1 904 | −1 557 | −385 | −4 935 | −1 446 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −106 | −1 171 | −2 139 | −4 903 | −1 904 | −1 557 | −385 | −4 935 | −1 446 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 30 | 2 540 | 4 107 | 1 377 | 426 | 646 | 381 | 2 956 | 4 912 |
| Equity | −82 | −1 253 | −2 793 | −5 792 | −6 706 | −7 870 | 245 | 3 020 | 2 864 |
| Long-term debt | 84 | 3 572 | 6 922 | 6 376 | 6 951 | 8 304 | 4 | 4 | 0 |
| Short-term debt | 28 | 222 | −22 | 793 | 181 | 211 | 132 | 4 867 | 2 047 |
| Total debt | 112 | 3 793 | 6 900 | 7 169 | 7 132 | 8 516 | 136 | 4 871 | 2 047 |
EBITDA margin
-65.6%
This company
15.8%
Market median
-515% vs market
20162024
Equity ratio
58.3%
This company
38.2%
Market median
+53% vs market
20162024
Return on equity
-50.5%
This company
18.4%
Market median
-374% vs market
20162024
Net profit margin
-67.1%
This company
8.1%
Market median
-928% vs market
20162024
Asset turnover
0.44×
This company
1.12×
Market median
-61% vs market
20162024
Debt / equity
0.71×
This company
0.62×
Market median
+15% vs market
20162024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
YM Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Cryoocyte Inc | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CRYOOCYTE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Yuri Mikhalev | Chief Executive Officer | 0 companies |
| Dmitry Kozachenok | Board of Directors | 0 companies |